These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15044963)

  • 1. Hapten-directed targeting to single-chain antibody receptors.
    Cheng TL; Liao KW; Tzou SC; Cheng CM; Chen BM; Roffler SR
    Cancer Gene Ther; 2004 May; 11(5):380-8. PubMed ID: 15044963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination cancer therapy by hapten-targeted prodrug-activating enzymes and cytokines.
    Chuang KH; Cheng CM; Roffler SR; Lu YL; Lin SR; Wang JY; Tzou WS; Su YC; Chen BM; Cheng TL
    Bioconjug Chem; 2006; 17(3):707-14. PubMed ID: 16704208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bystander killing of tumour cells by antibody-targeted enzymatic activation of a glucuronide prodrug.
    Cheng TL; Wei SL; Chen BM; Chern JW; Wu MF; Liu PW; Roffler SR
    Br J Cancer; 1999 Mar; 79(9-10):1378-85. PubMed ID: 10188879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerated clearance of polyethylene glycol-modified proteins by anti-polyethylene glycol IgM.
    Cheng TL; Wu PY; Wu MF; Chern JW; Roffler SR
    Bioconjug Chem; 1999; 10(3):520-8. PubMed ID: 10346886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hapten-derivatized nanoparticle targeting and imaging of gene expression by multimodality imaging systems.
    Cheng CM; Chu PY; Chuang KH; Roffler SR; Kao CH; Tseng WL; Shiea J; Chang WD; Su YC; Chen BM; Wang YM; Cheng TL
    Cancer Gene Ther; 2009 Jan; 16(1):83-90. PubMed ID: 18802451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific activation of glucuronide prodrugs by antibody-targeted enzyme conjugates for cancer therapy.
    Wang SM; Chern JW; Yeh MY; Ng JC; Tung E; Roffler SR
    Cancer Res; 1992 Aug; 52(16):4484-91. PubMed ID: 1643640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane-localized activation of glucuronide prodrugs by beta-glucuronidase enzymes.
    Chen KC; Cheng TL; Leu YL; Prijovich ZM; Chuang CH; Chen BM; Roffler SR
    Cancer Gene Ther; 2007 Feb; 14(2):187-200. PubMed ID: 16977328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A functional role for CD28 costimulation in tumor recognition by single-chain receptor-modified T cells.
    Moeller M; Haynes NM; Trapani JA; Teng MW; Jackson JT; Tanner JE; Cerutti L; Jane SM; Kershaw MH; Smyth MJ; Darcy PK
    Cancer Gene Ther; 2004 May; 11(5):371-9. PubMed ID: 15060573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folate receptor-targeted immunotherapy of cancer: mechanism and therapeutic potential.
    Lu Y; Sega E; Leamon CP; Low PS
    Adv Drug Deliv Rev; 2004 Apr; 56(8):1161-76. PubMed ID: 15094213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A membrane antibody receptor for noninvasive imaging of gene expression.
    Roffler SR; Wang HE; Yu HM; Chang WD; Cheng CM; Lu YL; Chen BM; Cheng TL
    Gene Ther; 2006 Mar; 13(5):412-20. PubMed ID: 16267569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant differences in biological parameters between prodrugs cleavable by carboxypeptidase G2 that generate 3,5-difluoro-phenol and -aniline nitrogen mustards in gene-directed enzyme prodrug therapy systems.
    Niculescu-Duvaz I; Scanlon I; Niculescu-Duvaz D; Friedlos F; Martin J; Marais R; Springer CJ
    J Med Chem; 2004 May; 47(10):2651-8. PubMed ID: 15115406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A sterically stabilized immunolipoplex for systemic administration of a therapeutic gene.
    Yu W; Pirollo KF; Rait A; Yu B; Xiang LM; Huang WQ; Zhou Q; Ertem G; Chang EH
    Gene Ther; 2004 Oct; 11(19):1434-40. PubMed ID: 15229629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(ethylene glycol) modification of beta-glucuronidase-antibody conjugates for solid-tumor therapy by targeted activation of glucuronide prodrugs.
    Cheng TL; Chen BM; Chan LY; Wu PY; Chern JW; Roffler SR
    Cancer Immunol Immunother; 1997 Aug; 44(6):305-15. PubMed ID: 9298932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents.
    Studeny M; Marini FC; Dembinski JL; Zompetta C; Cabreira-Hansen M; Bekele BN; Champlin RE; Andreeff M
    J Natl Cancer Inst; 2004 Nov; 96(21):1593-603. PubMed ID: 15523088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo prodrug therapy of prostate cancer using anti-gamma-Sm-scFv/hCPA fusion protein.
    Hao XK; Liu JY; Yue QH; Wu GJ; Bai YJ; Yin Y
    Prostate; 2006 Jun; 66(8):858-66. PubMed ID: 16491483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(ethylene glycol)-poly(ester-carbonate) block copolymers carrying PEG-peptidyl-doxorubicin pendant side chains: synthesis and evaluation as anticancer conjugates.
    Andersson L; Davies J; Duncan R; Ferruti P; Ford J; Kneller S; Mendichi R; Pasut G; Schiavon O; Summerford C; Tirk A; Veronese FM; Vincenzi V; Wu G
    Biomacromolecules; 2005; 6(2):914-26. PubMed ID: 15762660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose radiation potentiates the therapeutic efficacy of folate receptor-targeted hapten therapy.
    Sega EI; Lu Y; Ringor M; Leamon CP; Low PS
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):559-66. PubMed ID: 18411004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted lipid-coated nanoparticles: delivery of tumor necrosis factor-functionalized particles to tumor cells.
    Messerschmidt SK; Musyanovych A; Altvater M; Scheurich P; Pfizenmaier K; Landfester K; Kontermann RE
    J Control Release; 2009 Jul; 137(1):69-77. PubMed ID: 19306900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor targeting of doxorubicin by anti-MT1-MMP antibody-modified PEG liposomes.
    Hatakeyama H; Akita H; Ishida E; Hashimoto K; Kobayashi H; Aoki T; Yasuda J; Obata K; Kikuchi H; Ishida T; Kiwada H; Harashima H
    Int J Pharm; 2007 Sep; 342(1-2):194-200. PubMed ID: 17583453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell activation by monoclonal antibodies bound to tumor cells by a cell surface displayed single-chain antibody.
    Rode HJ; Moebius U; Little M
    J Immunol Methods; 1999 Apr; 224(1-2):151-60. PubMed ID: 10357215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.